{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:08:53Z","timestamp":1791554933598,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["037631"],"award-info":[{"award-number":["037631"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.clinthera.2008.12.021","type":"journal-article","created":{"date-parts":[[2009,1,23]],"date-time":"2009-01-23T05:00:35Z","timestamp":1232686835000},"page":"2314-2323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Effects of short-term and long-term danazol treatment on lipoproteins, coagulation, and progression of atherosclerosis: Two clinical trials in healthy volunteers and patients with hereditary angioedema"],"prefix":"10.1016","volume":"30","author":[{"given":"Rakesh S.","family":"Birjmohun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Kees Hovingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik S.G.","family":"Stroes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorit J.","family":"Hofstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geesje M.","family":"Dallinga-Thie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost C.M.","family":"Meijers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.P.","family":"Kastelein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2008.12.021_bib1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0140-6736(75)92376-4","article-title":"Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease","volume":"1","author":"Miller","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2008.12.021_bib2","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0140-6736(77)92274-7","article-title":"The Troms\u03b8 Heart-Study. High-density lipoprotein and coronary heart-disease: A prospective case-control study","volume":"1","author":"Miller","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2008.12.021_bib3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/314109a0","article-title":"Direct evidence that reverse cholesterol transport is mediated by high-density lipoprotein in rabbit","volume":"314","author":"Miller","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.clinthera.2008.12.021_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1161\/hc0102.102847","article-title":"Increased plasma C-reactive protein in familial hypoalphalipoproteinemia: A proinflammatory condition?","volume":"105","author":"Sampietro","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2008.12.021_bib5","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1161\/CIRCULATIONAHA.106.649954","article-title":"High-density lipoprotein and the risk of recurrent venous thromboembolism","volume":"115","author":"Eichinger","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2008.12.021_bib6","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1161\/01.CIR.0000070934.69310.1A","article-title":"Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein","volume":"107","author":"Bisoendial","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2008.12.021_bib7","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.jacc.2004.06.070","article-title":"A novel apoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease","volume":"44","author":"Hovingh","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2008.12.021_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jacc.2004.10.031","article-title":"Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: A meta-analysis of randomized controlled trials","volume":"45","author":"Birjmohun","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2008.12.021_bib9","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1743-6109.2007.00646.x","article-title":"Review of studies of androgen treatment of female-to-male transsexuals: Effects and risks of administration of androgens to females","volume":"5","author":"Gooren","year":"2008","journal-title":"J Sex Med"},{"issue":"Suppl 6","key":"10.1016\/j.clinthera.2008.12.021_bib10","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1097\/00005344-199306226-00016","article-title":"Serum lipoproteins during treatment with antihypertensive drugs","volume":"22","author":"Weidmann","year":"1993","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.clinthera.2008.12.021_bib11","first-page":"603","article-title":"Danazol in the treatment of endometriosis and hereditary angiooedema","volume":"237","author":"Hoogerbrugge","year":"1995","journal-title":"J Intern Med"},{"key":"10.1016\/j.clinthera.2008.12.021_bib12","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJM197612232952602","article-title":"Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities","volume":"295","author":"Gelfand","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2008.12.021_bib13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0165-2478(03)00029-4","article-title":"Increased expression of C1-inhibitor mRNA in patients with hereditary angioedema treated with danazol","volume":"86","author":"Pappalardo","year":"2003","journal-title":"Immunol Lett"},{"key":"10.1016\/j.clinthera.2008.12.021_bib14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jaci.2007.10.048","article-title":"Metallopeptidase activities in hereditary angioedema: Effect of androgen prophylaxis on plasma aminopeptidase P","volume":"121","author":"Drouet","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinthera.2008.12.021_bib15","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.jaci.2004.12.1130","article-title":"Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema","volume":"115","author":"Sz\u00e9plaki","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinthera.2008.12.021_bib16","first-page":"35","article-title":"Action of danazol on plasma lipids and lipoprotein metabolism","volume":"159","author":"Packard","year":"1994","journal-title":"Acta Obstet Gynecol Scand Suppl"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2008.12.021_bib17","first-page":"S23","article-title":"Danazol and plasma lipoprotein metabolism","volume":"50","author":"Shepherd","year":"1995","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.clinthera.2008.12.021_bib18","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.atherosclerosis.2007.09.025","article-title":"Long-term danazol prophylaxis does not lead to increased carotid intimamedia thickness in hereditary angioedema patients","volume":"198","author":"Szegedi","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinthera.2008.12.021_bib19","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinthera.2008.12.021_bib20","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1161\/01.CIR.0000070954.00271.13","article-title":"Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study","volume":"107","author":"Mackness","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2008.12.021_bib21","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/clinchem\/40.4.593","article-title":"Two-site enzyme immunoassay of cholesteryl ester transfer protein with monoclonal and oligoclonal antibodies","volume":"40","author":"Mezdour","year":"1994","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinthera.2008.12.021_bib22","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/CIRCULATIONAHA.105.540427","article-title":"Compromised LCAT function is associated with increased atherosclerosis","volume":"112","author":"Hovingh","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2008.12.021_bib23","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1365-2362.1994.tb00987.x","article-title":"Effect of adiposity on plasma lipid transfer protein activities: A possible link between insulin resistance and high density lipoprotein metabolism","volume":"24","author":"Dullaart","year":"1994","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.clinthera.2008.12.021_bib24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0021-9150(91)90110-O","article-title":"Different locations of cholesteryl ester transfer protein and phospholipid transfer protein activities in plasma","volume":"90","author":"Speijer","year":"1991","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinthera.2008.12.021_bib25","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jaci.2005.05.019","article-title":"A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema","volume":"116","author":"van Doorn","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinthera.2008.12.021_bib26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1210\/jcem-53-1-149","article-title":"Cholesterol, high density lipoprotein and danazol","volume":"53","author":"Allen","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2008.12.021_bib27","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/0002-9378(89)90870-3","article-title":"Metabolic changes during medical treatment of endometriosis: Nafarelin acetate versus danazol","volume":"160","author":"Burry","year":"1989","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2008.12.021_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000181334","article-title":"Zoladex versus danazol in the treatment of pelvic endometriosis: Effects on plasma lipid risk factors","volume":"32","author":"Crook","year":"1989","journal-title":"Horm Res"},{"key":"10.1016\/j.clinthera.2008.12.021_bib29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/00016348409157000","article-title":"Plasma lipoproteins during and after danazol treatment","volume":"123","author":"F\u00e5hraeus","year":"1984","journal-title":"Acta Obstet Gynecol Scand Suppl"},{"key":"10.1016\/j.clinthera.2008.12.021_bib30","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0015-0282(16)47957-4","article-title":"Profound alterations of the lipoprotein metabolism during danazol treatment in premenopausal women","volume":"42","author":"F\u00e5hraeus","year":"1984","journal-title":"Fertil Steril"},{"key":"10.1016\/j.clinthera.2008.12.021_bib31","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1479-828X.1991.tb01807.x","article-title":"A comparative treatment trial of endometriosis using the gonadotrophin-releasing hormone agonist, nafarelin, and the synthetic steroid, danazol","volume":"31","author":"Fraser","year":"1991","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.clinthera.2008.12.021_bib32","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJM198802253180805","article-title":"Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter doubleblind comparative clinical trial","volume":"318","author":"Henzl","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2008.12.021_bib33","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0015-0282(16)54893-6","article-title":"Nafarelin for endometriosis: A large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up","volume":"57","author":"The Nafarelin European Endometriosis Trial Group (NEET)","year":"1992","journal-title":"Fertil Steril"},{"key":"10.1016\/j.clinthera.2008.12.021_bib34","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1055\/s-2007-1014859","article-title":"Changes of plasma lipids and lipoprotein levels during danazol treatment for endometriosis","volume":"16","author":"Schweppe","year":"1984","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.clinthera.2008.12.021_bib35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0015-0282(16)60784-7","article-title":"Circulating lipid and lipoprotein concentrations during danazol and high-dose medroxyprogesterone acetate therapy of endometriosis","volume":"52","author":"Telimaa","year":"1989","journal-title":"Fertil Steril"},{"key":"10.1016\/j.clinthera.2008.12.021_bib36","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1210\/jcem-69-6-1097","article-title":"Comparison between the effects of nafarelin and danazol on serum lipids and lipoproteins in patients with endometriosis","volume":"69","author":"V\u00e4lim\u00e4ki","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2008.12.021_bib37","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0950-351X(05)80082-5","article-title":"Endocrine control of plasma lipoprotein metabolism: Effects of gonadal steroids","volume":"4","author":"Crook","year":"1990","journal-title":"Baillieres Clin Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2008.12.021_bib38","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1161\/ATVBAHA.106.136325","article-title":"High-density lipoprotein attenuates inflammation and coagulation response on endotoxin challenge in humans","volume":"27","author":"Birjmohun","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clinthera.2008.12.021_bib39","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/01.CIR.0000159351.95399.50","article-title":"Reconstituted high-density lipoproteins inhibit the acute prooxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits","volume":"111","author":"Nicholls","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2008.12.021_bib40","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood.V68.3.673.673","article-title":"Effect of danazol on clotting factor levels, bleeding incidence, factor infusion requirements, and immune parameters in hemophilia","volume":"68","author":"Saidi","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.clinthera.2008.12.021_bib41","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1182\/blood.V89.9.3213","article-title":"Activation of the coagulation cascade in C1-inhibitor deficiencies","volume":"89","author":"Cugno","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.clinthera.2008.12.021_bib42","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/0091-6749(94)90380-8","article-title":"Activation of the contact system and fibrinolysis in autoimmune acquired angioedema: A rationale for prophylactic use of tranexamic acid","volume":"93","author":"Cugno","year":"1994","journal-title":"J Allergy Clin Immunol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291808004566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291808004566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T06:24:45Z","timestamp":1754634285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291808004566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0149291808004566"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2008.12.021","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of short-term and long-term danazol treatment on lipoproteins, coagulation, and progression of atherosclerosis: Two clinical trials in healthy volunteers and patients with hereditary angioedema","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2008.12.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Excerpta Medica Inc. All rights reserved. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}